PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,701 stories, page 759 of 779

Advanced search
🇩🇪Researchdkfz.deTier 2 · Direct publisher

Download­bereich für Jour­nalist:innen

German Cancer Research Center (DKFZ)Original source
🇺🇸Industrydigitaldiagnostics.comTier 1 · Company source

Newsroom - Digital Diagnostics

IDx (Digital Diagnostics)Original source
🇺🇸Industrydigitaldiagnostics.comTier 1 · Company source

press-releases

IDx (Digital Diagnostics)Original source
🇺🇸Industrydigitaldiagnostics.comTier 1 · Company source

Insights & Engineering Insights - Digital Diagnostics

IDx (Digital Diagnostics)Original source
🇺🇸Industrydigitaldiagnostics.comTier 1 · Company source

Events - Digital Diagnostics

IDx (Digital Diagnostics)Original source
🇺🇸Industrydigitaldiagnostics.comTier 1 · Company source

Digital Media - Digital Diagnostics

IDx (Digital Diagnostics)Original source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Quality of life at work at Delpharm

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

New edition of the CSR report

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Meet us at DCAT!

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Investment in a new sterile filling line

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Discover the Delpharm Excellence System

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Discover our 2025 CSR report

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm Tours strengthens its expertise in sterile filling in accordance with Annex 1.

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm Tours strengthens its expertise in sterile filling. Discover our comprehensive offering.

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm to attend CDMO Live Europe 2026

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm strengthens its sterile vial capabilities

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm strengthens its centre of excellence dedicated to nasal sprays

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

DELPHARM SECURES MAJOR QUÉBEC GOVERNMENT SUPPORT TO MODERNIZE ITS BOUCHERVILLE FACILITY

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm secures corticoids manufacturing in France

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm is consolidating its expertise in sterile ampoules

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm invests heavily in its Boucherville site

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm Evreux obtains ANVISA certification

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm confirms its leadership in semi-solid forms

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm at Contract Pharma 2026

DelpharmOriginal source
🇫🇷CDMOdelpharm.comTier 2 · Direct publisher

Delpharm, a key partner for the manufacture of liquid medicines

DelpharmOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

TechSequences: The Productivity Paradox: Can AI Fix Pharma’s R&D Crisis? | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

R&D World: 25 techbio leaders that shaped the AI-biology convergence in 2024 | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

PharmaVoice: Biotech’s turning point: for every challenge, an opportunity in disguise | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Mendelspod: Big RNA with Brendan Frey of Deep Genomics January 30, 2025 https://www.mendelspod.com/p/big-rna-with-brenday-frey-of-deep

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Genetic Engineering and Biotechnology News: RNA Expands Its Clinical Clout | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Drug Discovery Trends: 100 cell and gene therapy leaders to watch in 2025 | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics Strengthens Momentum with Latest Executive Hires | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics Raises $40 Million in Series B Financing | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics Raises $180M in Series C Financing | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics Raises $13M to Develop Genetic Medicines | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics Introduces the Most Advanced AI Foundation Model for RNA Disease Mechanisms and Candidate Therapeutics | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Stat+: Deep Genomics founder: Why AI for drug discovery will far exceed current expectations | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics Expands Executive Leadership and Operations in Latest Strategic Growth Initiative | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics Expands AI Foundation Model Platform for Decoding RNA Biology | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics CEO Brian O’Callaghan honored as Gold Stevie® Award winner in 2025 Stevie Awards for Technology Excellence | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics Appoints Thong Q. Le as Chair of the Board of Directors | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Deep Genomics Announces the Appointment of Brian O’Callaghan as CEO | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Thong Q. Le and Paul Sekhri Join Board of Directors at Deep Genomics | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Biotech Leaders Guide Next Phase of Innovation and Growth for Deep Genomics as Members of Scientific Advisory Board | Deep Genomics

Deep GenomicsOriginal source
🇨🇦Industrydeepgenomics.comTier 1 · Company source

Between Two Coos Podcast September 30, 2026 https://betweentwocoos.com/tom-masterson-ai-drug-discovery-that-learned-the-rules/

Deep GenomicsOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Podcast: AI's impact on Global Pathology with AI Ireland

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Patholytix 4.0, Becomes First Platform to Support Future-proof Study Archival of Regulated Digital Safety Studies

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Diagnexia vs. Locums

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Diagnexia Unveils State-of-the-Art Histopathology Laboratory in Oxford

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Diagnexia Receives Accreditation from the College of American Pathologists

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Diagnexia Partners with Aga Khan University Hospital to Enhance Pathology Services and Foster AI Diagnostic Innovations

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Diagnexia Launches Global Education and Outreach Program to Bridge Diagnostic Gaps in Resource-Limited Regions

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Diagnexia UK Limited Achieves ISO 15189 Accreditation, Setting a New Benchmark for Safety and Reliability in Digital Pathology

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Full UKAS Accreditation for Oxford Histopathology Laboratory

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Diagnexia Accelerates Growth with Strategic Expansion within Exeter Science Park

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Deciphex Secures €31M Series C to Address Global Pathology Shortage

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Deciphex Reinforces Growth Trajectory in Global Pathology with Appointment of Industry Leader Greg Wigmore as CFO

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Deciphex Launches Diagnexia Analytix: AI-Driven Pathology Services for Translational Research and Development

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Deciphex launches CipherX: a step beyond foundation models, an AI engine for any pathology question

DeciphexOriginal source